Alexandria Real Estate Equities, Inc.

ARE · NYSE · USD

Analysis

Last 4 earnings calls · through Q2 FY2026

Alexandria has stopped building and started selling: with life science demand stalled for a fifth year, the calls show a landlord defending occupancy and shedding land while its rents fall faster than its costs. How much of the $2.9 billion of asset sales has actually closed?

  • The company swapped building for selling.

    The land bank is being cut from 20% of assets toward 10-15%, and $2.9 billion of sales and joint ventures are this year's main cash source. Closings keep slipping, so the money lands after the costs it pays for. Which asset types are left to sell under the $2.9 billion plan?

  • The leasing recovery is real, but the rent arrives late.

    Leasing bounced back last quarter, and space that is signed but still empty starts paying rent in November. Space expiring next year that carries $100.5 million of rent is expected to sit empty for up to two years. What does it cost to re-lease each square foot that goes vacant?

  • The tenants filling the space pay less.

    Q1 FY2026 brought no public biotech leases, and Q2 stayed thin while tools makers and advanced-technology users filled the gap. Those tenants fund more of their own fit-out, so space reopens for less cash but earns less rent.

Bullish
  • Cluster dominance in leasing
    The bull case is that Alexandria owns the lab clusters where tenants have to be, so it captures far more than its share of every lease signed in its markets.
  • Biotech funding recovery
    It also bets that capital is returning to biotech tenants, which management says is showing up in venture funding, public offerings and mid-sized space requirements.
  • Self-funded capital plan
    Management intends to fund construction and debt paydown by selling land and partial interests rather than issuing shares, which protects per-share results.
Bearish
  • Public biotech demand gap
    The bear case is that the tenants who anchor the portfolio are not expanding, and market share cannot fix a shrinking pool of laboratory demand.
  • Oversupplied lab submarkets
    Competing landlords built heavily during the boom, so Alexandria has to win leases with free rent and large build-out allowances that depress returns.
  • Known lease move-outs
    A block of large leases comes back with long expected downtime, so occupancy keeps falling even while new leasing activity improves.
PoliticiansInstitutionsInsiders
PoliticianTransactionAmountTradedFiled
Donald Trump
Republican · Executive
Sale≥$1KMay 22Jul 1
Donald Trump
Republican · Executive
Sale≥$1KMay 18Jul 1
Donald Trump
Republican · Executive
Sale≥$1KMar 26May 13
Donald Trump
Republican · Executive
Purchase≥$15KMar 18May 13
Donald Trump
Republican · Executive
Purchase≥$1KFeb 23May 13

Congressional trading data provided by QuiverQuant

Product segmentsGeography
FY2025 · USD

How Alexandria Real Estate Equities turned $3.0B of revenue into $0 of gross profit.

Revenue
Rental revenues$2.9B▼ 3.43% YoY
Product and Service, Other$81.4M▲ 22.03% YoY
Total revenue$3.0B